JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120270

Terfenadine, K+ channel blocker. H1 antagonist.

Be the first to review this product! Submit a review

|

(0 Publication)

MW 471.7 Da, Purity >98%. K+ channel blocker (Kv11.1). Blocks ATP-sensitive K+ channels (IC50 = 1.2 μM). H1 receptor antagonist.
2 Images
Immunocytochemistry/ Immunofluorescence - Terfenadine, K+ channel blocker. H1 antagonist. (AB120270)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Terfenadine, K+ channel blocker. H1 antagonist. (AB120270)

ab2893 staining γH2A.X in MALME-3M cells treated with terfenadine (ab120270), by ICC/IF. Increase of γH2A.X nuclear expression correlates with increased concentration of terfenadine, as described in literature.
The cells were incubated at 37°C for 6 hours in media containing different concentrations of ab120270 (terfenadine) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab2893 (10 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Chemical Structure - Terfenadine, K+ channel blocker. H1 antagonist. (AB120270)
  • Chemical Structure

Lab

Chemical Structure - Terfenadine, K+ channel blocker. H1 antagonist. (AB120270)

2D chemical structure image of ab120270, Terfenadine, K+ channel blocker. H1 antagonist.

Key facts

CAS number

50679-08-8

Purity

>98%

Form

Solid

form

Molecular weight

471.7 Da

Molecular formula

C<sub>3</sub><sub>2</sub>H<sub>4</sub><sub>1</sub>NO<sub>2</sub>

PubChem

5405

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

Terfenadine

Biological description

K+ channel blocker (Kv11.1). Blocks ATP-sensitive K+ channels (IC50 = 1.2 μM). H1 receptor antagonist.

Canonical smiles

CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O

InChi

InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3

InChiKey

GUGOEEXESWIERI-UHFFFAOYSA-N

IUPAC Name

1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MTOR also known as mechanistic target of rapamycin is a protein kinase involved in cell growth proliferation and survival. Expressed in various tissues including the brain skeletal muscles and liver mTOR functions as part of the mTORC1 and mTORC2 complexes. The protein itself has a molecular mass of about 289 kDa and acts as an important regulator of cell metabolism responding to nutrients growth factors and energy status.
Biological function summary

MTOR influences cellular processes like protein synthesis autophagy and lipid metabolism. It forms the core of two distinct complexes mTORC1 and mTORC2 each with unique substrates and functions. In mTORC1 mTOR regulates protein synthesis by phosphorylating key downstream effectors like 4E-BP1 and S6K1. Meanwhile mTORC2 primarily influences cell survival and cytoskeletal reorganization. Its expression profile makes it an essential player in maintaining cellular homeostasis.

Pathways

The mTOR signaling pathway is pivotal in integrating environmental signals to dictate cell fate. It interfaces with the PI3K/AKT pathway where mTORC1 receives upstream signals from AKT influencing protein synthesis and ribosome biogenesis. Concurrently mTORC2 phosphorylates AKT at a different site further potentiating signal transduction for cell survival. Other proteins within these pathways include TSC2 and Rheb which modulate mTOR activity in response to intracellular signals.

Abnormalities in mTOR signaling have connections with cancer and metabolic diseases. Hyperactivation of mTORC1 is often observed in various cancers such as breast and colon cancer due to its role in promoting cell growth and proliferation. Dysregulated mTOR activity also relates to metabolic disorders like type 2 diabetes characterized by impaired insulin signaling. In these contexts mTOR acts alongside other proteins like PTEN and LKB1 which function as tumor suppressors and metabolic regulators.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com